Business
Curavit-Lindus Deal Shifts CRO Capacity, but the Real Test Is Delivery
Curavit’s planned acquisition of Lindus Health CRO assets could broaden trial-delivery capacity, but price, scope and operating results remain undisclosed.
Curavit’s planned acquisition of Lindus Health CRO assets could broaden trial-delivery capacity, but price, scope and operating results remain undisclosed.